The Department is working closely with NHS England and NHS Improvement to support National Health Service healthcare providers ahead of winter. This includes £240 million of funding that has been made available to help patients with adult social care needs leave hospital when ready and free-up hospital capacity.<\/p>
As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the EU on 31 October.<\/p>
The Department continues to monitor and analyse overall staffing levels in the NHS and we have been monitoring leaver and joiner rates of EU staff on a regular basis since the 2016 referendum. We are not complacent and have plans in place to ensure there will continue to be sufficient staff to deliver the high-quality services on which the public relies. Our overall programme of work is comprehensive, thorough and continuously updated and will stand irrespective of the terms in which the United Kingdom leaves the EU.<\/p>
The Department is also working more broadly with delivery partners to ensure that the health and care system as a whole is prepared and ready to respond to disruption caused by EU exit.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4021", "label" : {"_value" : "Biography information for Chris Skidmore"} } , "answeringMemberConstituency" : {"_value" : "Kingswood"} , "answeringMemberPrinted" : {"_value" : "Chris Skidmore"} , "dateOfAnswer" : {"_value" : "2019-09-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-09-09T19:07:24.123Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-09-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Finance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans the Government has to support healthcare providers through winter 2019 in the event that the UK leaves the EU without a withdrawal agreement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4666", "label" : {"_value" : "Biography information for Dr Paul Williams"} } , "tablingMemberConstituency" : {"_value" : "Stockton South"} , "tablingMemberPrinted" : [{"_value" : "Dr Paul Williams"} ], "uin" : "284153"} , {"_about" : "http://data.parliament.uk/resources/1142686", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1142686/answer", "answerText" : {"_value" : "
As set out in the NHS Long Term Plan, the National Health Service is committed to supporting the timely introduction of the most clinically and cost effective treatments for patients. Cell and gene therapies have the potential to provide great benefits for patients, and the NHS is leading the world in creating access to these treatments.<\/p>
For example, patients in England were among the first in the world to benefit from CAR T cell therapy, which uses their own immune system to fight cancers. The NHS will also now be funding voretigene neparvovec, also known as Luxturna, a revolutionary form of new treatment for blindness in children.<\/p>
The NHS is working with the National Institute for Health and Care Excellence and other partners in the Accelerated Access Collaborative to take a proactive approach in preparing for cell and gene therapies and other innovative treatments.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"} } , "answeringMemberConstituency" : {"_value" : "Gosport"} , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"} , "dateOfAnswer" : {"_value" : "2019-09-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-09-09T17:29:21.393Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-09-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Gene Therapies"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans NHS England has to implement gene therapy treatments.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4609", "label" : {"_value" : "Biography information for Eleanor Smith"} } , "tablingMemberConstituency" : {"_value" : "Wolverhampton South West"} , "tablingMemberPrinted" : [{"_value" : "Eleanor Smith"} ], "uin" : "284172"} , {"_about" : "http://data.parliament.uk/resources/1142687", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1142687/answer", "answerText" : {"_value" : "
The United Kingdom National Screening Committee (UK NSC) advises ministers and the National Health Service in the four UK countries about all aspects of screening and supports implementation of screening programmes. All screening programmes are introduced following a robust process using peer reviewed evidence that shows the benefits to screen clearly outweigh harm.<\/p>
Earlier this year, the UK NSC looked at the evidence to offer population screening for cystic fibrosis (CF) in pregnancy and recommended that this should not be introduced. This is because screening during pregnancy would be difficult. Further, there is no new evidence to support screening. Ministers accepted this recommendation.<\/p>
However, the NHS Newborn Blood spot Screening Programme screens for cystic fibrosis in newborn babies alongside eight other conditions. Newborn blood spot screening in England is offered between five and eight days after the baby is born. <\/em><\/p> <\/strong><\/p> <\/em><\/strong><\/p> <\/strong><\/p> <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-09-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-09-09T18:17:04.987Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-09-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cystic Fibrosis: Diagnosis"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential merits of making cystic fibrosis checks routine in (a) antenatal care and (b) neonatal care.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4368", "label" : {"_value" : "Biography information for Neil Coyle"}
}
, "tablingMemberConstituency" : {"_value" : "Bermondsey and Old Southwark"}
, "tablingMemberPrinted" : [{"_value" : "Neil Coyle"}
], "uin" : "284174"}
, {"_about" : "http://data.parliament.uk/resources/1142688", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1142688/answer", "answerText" : {"_value" : " It has not proved possible to respond to the hon. Member in the time available before Prorogation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
}
, "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
, "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
, "dateOfAnswer" : {"_value" : "2019-09-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-09-09T17:27:04.567Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-09-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to make the stabilisation of conditions such as cystic fibrosis part of the NICE quality of life measurement system and not just extension of life.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4368", "label" : {"_value" : "Biography information for Neil Coyle"}
}
, "tablingMemberConstituency" : {"_value" : "Bermondsey and Old Southwark"}
, "tablingMemberPrinted" : [{"_value" : "Neil Coyle"}
], "uin" : "284175"}
, {"_about" : "http://data.parliament.uk/resources/1142690", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1142690/answer", "answerText" : {"_value" : " It has not proved possible to respond to the hon. Member in the time available before Prorogation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
}
, "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
, "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
, "dateOfAnswer" : {"_value" : "2019-09-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-09-09T17:40:30.007Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-09-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Screening"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the full NHS People Plan will tackle shortages in the imaging and diagnostic workforce in order to achieve the ambition in the NHS Long Term Plan to increase cancer screening uptake.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3936", "label" : {"_value" : "Biography information for Andrew Griffiths"}
}
, "tablingMemberConstituency" : {"_value" : "Burton"}
, "tablingMemberPrinted" : [{"_value" : "Andrew Griffiths"}
], "uin" : "284178"}
, {"_about" : "http://data.parliament.uk/resources/1142692", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1142692/answer", "answerText" : {"_value" : " Further to the answer the Minister of State for Care (Caroline Dinenage MP) gave on 2 April 2019 to Question 236381, that NHS England has considered this issue, and does not believe that a gap has been created as a result of the closure of Commissioning Support Programme for treatments that are awaiting review by the Clinical Priorities Advisory Group.<\/p> The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme.<\/p> All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage for post stakeholder testing. These are now being progressed though the usual development process. Further information is available at the following link:<\/p>